Peptide self-assembled nanomedicine induces antitumor immunity by blocking the PD-1/PD-L1 axis

Peptide self-assembled nanomedicine induces antitumor immunity by blocking the PD-1/PD-L1 axis

The development of immune checkpoint inhibitors (ICIs) revolutionizes cancer treatment, which has been applied in the treatment of several kinds of malignancies in the clinic. Due to their specific affinity and controllable cost, the emerging peptide-based ICI therapeutics have attracted great atten...

Full description

Bibliographic Details
Main Authors: Tao Huang, Xianfu Sun, Xiaocao Meng, Mengdie Chen, Yapeng Li, Shengnan Du, Yingqiu Qi, Hong Ge
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Materials
Subjects:
immune checkpoint inhibitors (ICIs)
nanomedicine
antitumor immunity
peptides
PD-L1
PD-1
Online Access:https://www.frontiersin.org/articles/10.3389/fmats.2022.1056600/full

Internet

https://www.frontiersin.org/articles/10.3389/fmats.2022.1056600/full

Similar Items